Becton, Dickinson and Co. | BDX - مصاريف البيع والإدارة

سعر السهم
154.15
التغيير اليومي
-0.36 -0.23%
شهريا
-12.68%
سنويا
-32.70%
Q1 التوقعات
149.87




مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 3.13B 125M 2025-12
Agilent USD 476M 48M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Bio-Rad Laboratories USD 206.8M 900K 2025-09
Boston Scientific USD 1.83B 93M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Danaher USD 2.03B 35M 2025-12
Dentsply International USD 383M 28M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
Globus Medical USD 318.48M 4.88M 2025-12
Hologic USD 2.5B 2.24B 2025-12
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 687.1M 113.8M 2025-12
J&J USD 6.75B 831M 2025-12
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Solventum Corp USD 759M 15M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Terumo JPY 105.26B 7.38B 2025-12
Thermo Fisher Scientific USD 1.98B 182M 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12